Compounding Knowledge: Leading with Clarity: Communication Strategies for Designated Persons - December 2026
Includes a Live Web Event on 12/02/2026 at 12:00 PM (EST)
Recorded On: 12/02/2026
-
Register
- Prices available after logging in
One of the most challenging roles of the Designated Person (DP) is managing team members who do not follow established policies. This session covers strategies to engage noncompliant staff, uncover root causes of resistance, and communicate the "why" behind the guidance. Learn communication tools that foster accountability while maintaining team morale and safety culture.
- Identify common reasons for staff noncompliance and assess root causes behind resistance to established policies.
- Apply communication techniques that improve clarity, accountability, and team engagement in sterile compounding environments.
- Demonstrate strategies for reinforcing safety culture while maintaining morale and supporting staff development.
Gene Decaminada, RPh, BSPharm, FNHIA
Pharmacy Manager Home Infusion
Yale New Haven Health
Gene Decaminada is currently the Pharmacy Manager for the Home Infusion Program at Yale New Haven Health Services (YNHHS). NHIA Fellowship Award (2021); CPA mentor (2021, 2022) YNHHS Mentor (2022); NHIA Peer Review Member (2021); CPA Professional Pharmacy Performance Award (2021); BPS Sterile Compounding Council Member (term concluded 12/31/21); former NHIA National Standards and Sterile Compounding Education Committee member; PTCB Certificate Program instructor CT Community College (2021); CPA Sterile Compounding Conference Committee member; NHIA Sterile Compounding Practice Committee (SCPC) member; Vizient Home Infusion subcommittee member; and a selected member of the Institute for Excellence at YNHHS Lean-In Class of 2022.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Gene Decaminada has no relevant financial relationships with ineligible companies to disclose.
